BDHK-2009

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameBDHK-2009
Drug Alias NameBDHK-2009BDHK2009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRegulatory T-lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBenethera (Shaoxing) Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBenethera (Shaoxing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A